Details for New Drug Application (NDA): 090019
✉ Email this page to a colleague
The generic ingredient in PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are four hundred and twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.
Summary for 090019
Tradename: | PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE |
Applicant: | Novel Labs Inc |
Ingredient: | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride |
Patents: | 0 |
Pharmacology for NDA: 090019
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion |
Suppliers and Packaging for NDA: 090019
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION;ORAL | 090019 | ANDA | Lupin Pharmaceuticals,Inc. | 43386-050 | 43386-050-19 | 438.4 g in 1 BOTTLE (43386-050-19) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | ||||
Approval Date: | May 27, 2009 | TE: | AA | RLD: | No |
Complete Access Available with Subscription